Over the past 12 months, 11 insiders at COLLEGIUM PHARMACEUTICAL, INC filed 20 open-market SEC Form 4 transactions on COLL: 0 purchases worth $0 and 20 sales worth $10.3M. Insiders have been net sellers over this period. The most recent filing was on May 18, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 26 | John Gordon Freund | SELL | 20 | $34.05 | $681 |
| May 15, 26 | John Gordon Freund | SELL | 4.1K | $34.54 | $143K |
| May 13, 26 | Nancy Lurker | SELL | 4.5K | $35.97 | $162K |
| May 11, 26 | Garen G Bohlin | SELL | 8.7K | $37.18 | $323K |
| Mar 18, 26 | David DieterEVP & General Counsel | SELL | 14.0K | $34.92 | $488K |
| Mar 9, 26 | David DieterEVP & General Counsel | SELL | 6.2K | $36.65 | $228K |
| Mar 3, 26 | Scott DreyerEVP & Chief Commercial Officer | SELL | 46.4K | $40.99 | $1.9M |
| Dec 8, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 11.1K | $48.66 | $533K |
| Dec 5, 25 | Rita J. Balice-gordonDirector | SELL | 3.6K | $47.03 | $172K |
| Nov 12, 25 | John A. FallonDirector | SELL | 34.9K | $47.21 | $1.6M |
| Nov 6, 25 | Colleen TupperEVP & Chief Financial Officer | SELL | 25.1K | $41.28 | $1.0M |
| Aug 29, 25 | Thomas B SmithEVP and Chief Medical Officer | SELL | 17.5K | $38.42 | $672K |
| Aug 18, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 16.4K | $38.21 | $626K |
| Aug 15, 25 | Gino SantiniDirector | SELL | 5.4K | $37.19 | $201K |
| Aug 13, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 4.9K | $38.03 | $185K |
| Aug 13, 25 | Rubric Capital Management LpTenPercentOwner | SELL | 25.0K | $37.85 | $946K |
| Aug 8, 25 | John Gordon FreundDirector | SELL | 11.7K | $34.36 | $401K |
| Jun 9, 25 | John Gordon FreundDirector | SELL | 6.6K | $30.62 | $202K |
| Mar 21, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 18.9K | $30.03 | $567K |
| Mar 21, 25 | Colleen TupperEVP & Chief Financial Officer | SELL | 6.4K | $30.03 | $192K |
| Mar 20, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 1.9K | $30.00 | $58K |
| Mar 20, 25 | Colleen TupperEVP & Chief Financial Officer | SELL | 1.2K | $30.00 | $36K |
| Mar 14, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 2.3K | $30.00 | $68K |
| Mar 14, 25 | Colleen TupperEVP & Chief Financial Officer | SELL | 977 | $30.00 | $29K |
| Mar 11, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 15.4K | $30.00 | $462K |
| Mar 11, 25 | Colleen TupperEVP & Chief Financial Officer | SELL | 10.4K | $30.01 | $313K |
| Mar 7, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 2.3K | $30.00 | $70K |
| Mar 7, 25 | Colleen TupperEVP & Chief Financial Officer | SELL | 1.5K | $30.00 | $45K |
| Mar 6, 25 | Scott DreyerEVP & Chief Commercial Officer | SELL | 15.4K | $30.00 | $462K |
| Mar 6, 25 | Colleen TupperEVP & Chief Financial Officer | SELL | 1.9K | $30.00 | $58K |
| Mar 6, 25 | Shirley R. KuhlmannEVP and General Counsel | SELL | 26.1K | $28.50 | $743K |
| Mar 5, 25 | Shirley R. KuhlmannEVP and General Counsel | SELL | 20.0K | $28.03 | $561K |
| Mar 4, 25 | Shirley R. KuhlmannEVP and General Counsel | SELL | 40.0K | $28.08 | $1.1M |
| Jan 10, 25 | Shirley R. KuhlmannEVP and General Counsel | SELL | 21.4K | $33.64 | $703K |
| Sep 13, 24 | Thomas B SmithEVP and Chief Medical Officer | SELL | 9.6K | $36.62 | $351K |
| Sep 6, 24 | Shirley R. KuhlmannEVP and General Counsel | SELL | 977 | $37.46 | $37K |
| Sep 5, 24 | Shirley R. KuhlmannEVP and General Counsel | SELL | 16.8K | $39.14 | $643K |
| Jun 3, 24 | Shirley R. KuhlmannEVP and General Counsel | SELL | 24.3K | $33.22 | $791K |
| May 28, 24 | Colleen TupperEVP & Chief Financial Officer | SELL | 19.7K | $34.21 | $674K |
| May 24, 24 | Scott DreyerEVP & Chief Commercial Officer | SELL | 56.8K | $33.98 | $1.9M |
| May 23, 24 | Scott DreyerEVP & Chief Commercial Officer | SELL | 51.2K | $33.82 | $1.7M |
| May 14, 24 | Garen G BohlinDirector | SELL | 29.0K | $32.30 | $936K |
| Feb 29, 24 | Thomas B SmithEVP and Chief Medical Officer | SELL | 995 | $36.76 | $37K |
| Feb 26, 24 | Scott DreyerEVP & Chief Commercial Officer | SELL | 9.3K | $37.15 | $340K |
| Jan 16, 24 | Scott DreyerEVP & Chief Commercial Officer | SELL | 23.6K | $32.28 | $761K |
| Dec 21, 23 | Joseph CiaffoniPresident and CEO | SELL | 4.4K | $30.38 | $132K |
| Dec 20, 23 | Joseph CiaffoniPresident and CEO | SELL | 26.5K | $30.40 | $804K |
| Dec 19, 23 | Joseph CiaffoniPresident and CEO | SELL | 14.5K | $30.03 | $436K |
| Dec 18, 23 | Joseph CiaffoniPresident and CEO | SELL | 27.8K | $30.04 | $835K |
| Nov 27, 23 | Shirley R. KuhlmannEVP and General Counsel | SELL | 25.6K | $25.78 | $660K |
Over the past 12 months, insiders at COLLEGIUM PHARMACEUTICAL, INC filed 0 open-market purchases worth $0 and 20 sales worth $10.3M on COLL, which makes them net sellers over the period. The most recent Form 4 was filed on May 18, 26.
11 different insiders at COLLEGIUM PHARMACEUTICAL, INC filed open-market SEC Form 4 transactions on COLL over the last 12 months.
InsiderTape plots every COLL insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every COLLEGIUM PHARMACEUTICAL, INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →